Skip to content

TuHURA Biosciences, Inc. HURA Market capitalization

Market capitalization at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$123.83B-0.2%
CTO
Citius Oncology, Inc.CTOR
$54.72M-17.8%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
$982.03M+385%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$1.23B+467%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$7.92B+208%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$340.23M+298%

Other financials

Income statement

See full
Revenue-
Net income-$7.5M-13.1%
EPS (diluted)-$0.13+13.3%

Balance sheet

See full
Cash & equivalents$6.3M+1.3%
Total debt$456.9K+178%
Total equity$23.2M+135%
Total assets$29.7M+103%

Cash flow

See full
Operating cash flow-$4.4M+6.9%
CapEx$48.8K+14.5%
Free cash flow-$4.5M+6.7%

Valuation

See full
Enterprise value$149.54M+52.3%

Returns & leverage

See full
Return on equity-187.2%
Debt / equity0.0×
Current ratio1.2×-1.8×

Where this comes from

Computed from the period-end share price: $101.1M.

The official record: TuHURA Biosciences, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about TuHURA Biosciences, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TuHURA Biosciences, Inc.'s market capitalization?
TuHURA Biosciences, Inc. (HURA) reported market capitalization of $101.1M in Q1 2026.
How has TuHURA Biosciences, Inc.'s market capitalization changed year-over-year?
TuHURA Biosciences, Inc.'s market capitalization decreased by 26.0% year-over-year, from $136.7M to $101.1M.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.